SCHEMBL20381978

SCHEMBL20381978

CCN1CCN(Cc2ccccc2OC)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.62
MEN1 O00255 4/20 0.62
KDM4E B2RXH2 4/20 0.62
ALDH1A1 P00352 3/20 0.62
SIGMAR1 Q99720 1/20 0.60
GNAI3 P08754 1/20 0.58
USP2 O75604 1/20 0.58
CYP2D6 P10635 1/20 0.58
CHRM2 P08172 1/20 0.58
CHRM4 P08173 1/20 0.58
CHRM5 P08912 1/20 0.58
CHRM1 P11229 1/20 0.58
CHRM3 P20309 1/20 0.58
KCNH2 Q12809 1/20 0.58
HTR1A P08908 1/20 0.58
DRD2 P14416 1/20 0.58
HTR2B P41595 1/20 0.58
ALOX15 P16050 1/20 0.58
HTT P42858 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12856249 0.88 MEN1 (0.72) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL13559793 0.86 SIGMAR1 (0.65) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL13284339 0.86 MEN1 (0.79) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL27882880 0.85 KDM4E (0.60) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL3161038 0.84 MEN1 (0.82) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL27448022 0.84 KDM4E (0.56) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL9096094 0.82 SIGMAR1 (0.64) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL9094866 0.82 SIGMAR1 (0.64) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL18704979 0.82 MEN1 (0.57) KMT2AMEN1KDM4EALDH1A1SIGMAR1
SCHEMBL28126563 0.82 SIGMAR1 (0.64) KMT2AMEN1KDM4EALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023570-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2018-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023570-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, ROR1, BRAF KMT2A 1448/4885MEN1 1015/4885KDM4E 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.